IDEAYA Biosciences, Inc., a precision medicine oncology company, announced on June 27, 2025, that its Board of Directors' Compensation Committee has granted non-qualified stock options for a total of 95,600 shares to a newly hired employee. These options, issued under the IDEAYA Biosciences, Inc. 2023 Employment Inducement Incentive Award Plan, were given as an inducement for joining the company. The stock options have an exercise price of $22.29 per share, corresponding to the closing price on the Nasdaq Global Select Market on the grant date. With a 10-year term, the options vest over four years, starting with 25% after the first year and the remaining 75% in equal monthly installments over the subsequent three years, contingent on the employee's continued service to IDEAYA.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。